Trial Outcomes & Findings for Evaluating Mobility Interventions in the Real World (NCT NCT04275973)

NCT ID: NCT04275973

Last Updated: 2025-12-19

Results Overview

Minimum Foot Clearance with different prostheses, participants crossover to each of 4 different conditions at different study visits, data collected up to 12 weeks on study.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

20 participants

Primary outcome timeframe

Weekly time points for Prosthetic interventions (baseline, 1, 2, 3, and 4 weeks), data collected anytime up to 12 weeks on study

Results posted on

2025-12-19

Participant Flow

Healthy control participants were not consented or enrolled.

Participant milestones

Participant milestones
Measure
Prosthesis User With Transtibial or Transfemoral Amputation
Experiments will use standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA). Lower limb prostheses: Standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA).
Orthoses User With Drop-foot
This arm will consists of participants with drop-foot. All of the drop-foot population were persons with Multiple Sclerosis. For participants in this arm, standard commercially-available orthoses or standard-of-care custom orthoses will be used, as well as standard commercially-available electrical stimulation neuro-orthoses. Orthoses for Drop-foot: Standard commercially-available orthoses or standard-of-care custom orthoses as well as standard commercially-available electrical stimulation neuro-orthoses.
Overall Study
STARTED
8
12
Overall Study
Low Profile Foot
5
0
Overall Study
Energy Storage and Return Foot
5
0
Overall Study
Passive Hydraulic Ankle
5
0
Overall Study
Microprocessor Hydraulic Ankle
2
0
Overall Study
No Intervention
0
11
Overall Study
Ankle Foot Orthosis (AFO)
0
11
Overall Study
Functional Electrical Stimulation (FES) Device
0
11
Overall Study
COMPLETED
6
11
Overall Study
NOT COMPLETED
2
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Prosthesis User With Transtibial or Transfemoral Amputation
Experiments will use standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA). Lower limb prostheses: Standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA).
Orthoses User With Drop-foot
This arm will consists of participants with drop-foot. All of the drop-foot population were persons with Multiple Sclerosis. For participants in this arm, standard commercially-available orthoses or standard-of-care custom orthoses will be used, as well as standard commercially-available electrical stimulation neuro-orthoses. Orthoses for Drop-foot: Standard commercially-available orthoses or standard-of-care custom orthoses as well as standard commercially-available electrical stimulation neuro-orthoses.
Overall Study
Withdrawal by Subject
2
1

Baseline Characteristics

Evaluating Mobility Interventions in the Real World

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Prosthesis User With Transtibial or Transfemoral Amputation
n=6 Participants
Experiments will use standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA). Lower limb prostheses: Standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA).
Orthoses User With Drop-foot
n=11 Participants
This arm will consists of participants with drop-foot. All of the drop-foot population were persons with Multiple Sclerosis. For participants in this arm, standard commercially-available orthoses or standard-of-care custom orthoses will be used, as well as standard commercially-available electrical stimulation neuro-orthoses. Orthoses for Drop-foot: Standard commercially-available orthoses or standard-of-care custom orthoses as well as standard commercially-available electrical stimulation neuro-orthoses.
Total
n=17 Participants
Total of all reporting groups
Age, Continuous
57 years
n=8 Participants
43 years
n=6 Participants
48 years
n=6 Participants
Sex: Female, Male
Female
3 Participants
n=8 Participants
7 Participants
n=6 Participants
10 Participants
n=6 Participants
Sex: Female, Male
Male
3 Participants
n=8 Participants
4 Participants
n=6 Participants
7 Participants
n=6 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=8 Participants
0 Participants
n=6 Participants
0 Participants
n=6 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants
n=8 Participants
0 Participants
n=6 Participants
0 Participants
n=6 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
6 Participants
n=8 Participants
11 Participants
n=6 Participants
17 Participants
n=6 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=8 Participants
0 Participants
n=6 Participants
0 Participants
n=6 Participants
Race (NIH/OMB)
Asian
0 Participants
n=8 Participants
0 Participants
n=6 Participants
0 Participants
n=6 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=8 Participants
0 Participants
n=6 Participants
0 Participants
n=6 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=8 Participants
0 Participants
n=6 Participants
0 Participants
n=6 Participants
Race (NIH/OMB)
White
0 Participants
n=8 Participants
0 Participants
n=6 Participants
0 Participants
n=6 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=8 Participants
0 Participants
n=6 Participants
0 Participants
n=6 Participants
Race (NIH/OMB)
Unknown or Not Reported
6 Participants
n=8 Participants
11 Participants
n=6 Participants
17 Participants
n=6 Participants
Region of Enrollment
United States
6 participants
n=8 Participants
11 participants
n=6 Participants
17 participants
n=6 Participants
Participants Diagnosed with Multiple Sclerosis (MS)
0 Participants
n=8 Participants
11 Participants
n=6 Participants
11 Participants
n=6 Participants

PRIMARY outcome

Timeframe: Weekly time points for Prosthetic interventions (baseline, 1, 2, 3, and 4 weeks), data collected anytime up to 12 weeks on study

Population: All participants did not complete tests with all prostheses.

Minimum Foot Clearance with different prostheses, participants crossover to each of 4 different conditions at different study visits, data collected up to 12 weeks on study.

Outcome measures

Outcome measures
Measure
Prosthesis User With Transtibial or Transfemoral Amputation
n=6 Participants
Experiments will use standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA). Lower limb prostheses: Standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA).
Orthoses User With Drop-foot
This arm will consists of participants with drop-foot. All of the drop-foot population were persons with Multiple Sclerosis. For participants in this arm, standard commercially-available orthoses or standard-of-care custom orthoses will be used, as well as standard commercially-available electrical stimulation neuro-orthoses. Orthoses for Drop-foot: Standard commercially-available orthoses or standard-of-care custom orthoses as well as standard commercially-available electrical stimulation neuro-orthoses.
Minimum Foot Clearance With Different Prostheses
Low Profile Foot
0.02117 meters
Standard Deviation 0.005247
Minimum Foot Clearance With Different Prostheses
Energy Storage and Return Foot
0.01976 meters
Standard Deviation 0.007828
Minimum Foot Clearance With Different Prostheses
Passive Hydraulic Ankle
0.01932 meters
Standard Deviation 0.004138
Minimum Foot Clearance With Different Prostheses
Microprocessor Hydraulic Ankle
0.03055 meters
Standard Deviation 0.001360

PRIMARY outcome

Timeframe: Baseline, 10 days, and 20 days for Orthotic interventions

Population: 1 participant could not be assessed for this measure

Minimum Foot Clearance with different orthoses, participants crossover to each of 3 different conditions at different study visits, data collected up to 20 days on study.

Outcome measures

Outcome measures
Measure
Prosthesis User With Transtibial or Transfemoral Amputation
n=10 Participants
Experiments will use standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA). Lower limb prostheses: Standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA).
Orthoses User With Drop-foot
This arm will consists of participants with drop-foot. All of the drop-foot population were persons with Multiple Sclerosis. For participants in this arm, standard commercially-available orthoses or standard-of-care custom orthoses will be used, as well as standard commercially-available electrical stimulation neuro-orthoses. Orthoses for Drop-foot: Standard commercially-available orthoses or standard-of-care custom orthoses as well as standard commercially-available electrical stimulation neuro-orthoses.
Minimum Foot Clearance With Different Orthoses
Ankle Foot Orthosis
0.721081 centimeters
Standard Deviation 0.857378
Minimum Foot Clearance With Different Orthoses
Functional Electrical Stimulation Device
0.81136 centimeters
Standard Deviation 1.105746
Minimum Foot Clearance With Different Orthoses
No Intervention
0.56469 centimeters
Standard Deviation 0.662561

SECONDARY outcome

Timeframe: Weekly time points for Prosthetic interventions (baseline, 1, 2, 3, and 4 weeks), data collected anytime up to 12 weeks on study

Population: All participants did not complete tests with all prostheses.

Behavioral gait function will be measured by daily stride count (strides per sensor hour, Prosthetics only), participants crossed over to each of 4 different conditions at different study visits, data collected up to 12 weeks on study.

Outcome measures

Outcome measures
Measure
Prosthesis User With Transtibial or Transfemoral Amputation
n=6 Participants
Experiments will use standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA). Lower limb prostheses: Standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA).
Orthoses User With Drop-foot
This arm will consists of participants with drop-foot. All of the drop-foot population were persons with Multiple Sclerosis. For participants in this arm, standard commercially-available orthoses or standard-of-care custom orthoses will be used, as well as standard commercially-available electrical stimulation neuro-orthoses. Orthoses for Drop-foot: Standard commercially-available orthoses or standard-of-care custom orthoses as well as standard commercially-available electrical stimulation neuro-orthoses.
Behavioral Gait Function as Measured From Daily Stride Count
Low Profile Foot
264.9 strides per sensor hour
Standard Deviation 177.0
Behavioral Gait Function as Measured From Daily Stride Count
Energy Storage and Return Foot
245.7 strides per sensor hour
Standard Deviation 113.1
Behavioral Gait Function as Measured From Daily Stride Count
Passive Hydraulic Ankle
230.9 strides per sensor hour
Standard Deviation 117.8
Behavioral Gait Function as Measured From Daily Stride Count
Microprocessor Hydraulic Ankle
269.3 strides per sensor hour
Standard Deviation 92.49

SECONDARY outcome

Timeframe: Weekly time points for Prosthetic interventions (baseline, 1, 2, 3, and 4 weeks), data collected anytime up to 12 weeks on study

Population: Participants had varying ability to walk at different speeds.

Behavioral gait function will be measured by average stride speed, participants crossover to each of 4 different conditions at different study visits, data collected up to 12 weeks on study.

Outcome measures

Outcome measures
Measure
Prosthesis User With Transtibial or Transfemoral Amputation
n=6 Participants
Experiments will use standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA). Lower limb prostheses: Standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA).
Orthoses User With Drop-foot
This arm will consists of participants with drop-foot. All of the drop-foot population were persons with Multiple Sclerosis. For participants in this arm, standard commercially-available orthoses or standard-of-care custom orthoses will be used, as well as standard commercially-available electrical stimulation neuro-orthoses. Orthoses for Drop-foot: Standard commercially-available orthoses or standard-of-care custom orthoses as well as standard commercially-available electrical stimulation neuro-orthoses.
Behavioral Gait Function as Measured From Stride Speed During Walking Bouts of Different Durations
less than 10 seconds
0.4685 meters per second
Standard Deviation 0.049
Behavioral Gait Function as Measured From Stride Speed During Walking Bouts of Different Durations
10 to 30 seconds
0.7155 meters per second
Standard Deviation 0.0936
Behavioral Gait Function as Measured From Stride Speed During Walking Bouts of Different Durations
30-60 seconds
0.906 meters per second
Standard Deviation 0.1172
Behavioral Gait Function as Measured From Stride Speed During Walking Bouts of Different Durations
60-120 seconds
0.9652 meters per second
Standard Deviation 0.1562
Behavioral Gait Function as Measured From Stride Speed During Walking Bouts of Different Durations
greater than 120 seconds
1.0486 meters per second
Standard Deviation 0.1979

SECONDARY outcome

Timeframe: up to 12 weeks

Population: All participants did not complete tests with all prostheses.

The Prosthetic Limb Users Survey of Mobility (PLUS-M) is a 12 item questionnaire. It is a self-report instrument for measuring mobility of adults with lower limb amputation. PLUS-M instruments measure prosthetic users' mobility (i.e., the ability to move intentionally and independently from one place to another). PLUS-M questions assess respondents' perceived ability to carry out actions that require use of both lower limbs, ranging from household ambulation to outdoor recreational activities. The described activities relate to two primary forms of movement, locomotion (i.e., movement in a continuous, repeatable pattern) and/or postural transitions (i.e., movement from one position to another or one type of activity to another). PLUS-M instruments provide a T-score that averages 50 with a standard deviation of 10. A higher PLUS-M T-score corresponds to greater mobility.

Outcome measures

Outcome measures
Measure
Prosthesis User With Transtibial or Transfemoral Amputation
n=6 Participants
Experiments will use standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA). Lower limb prostheses: Standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA).
Orthoses User With Drop-foot
This arm will consists of participants with drop-foot. All of the drop-foot population were persons with Multiple Sclerosis. For participants in this arm, standard commercially-available orthoses or standard-of-care custom orthoses will be used, as well as standard commercially-available electrical stimulation neuro-orthoses. Orthoses for Drop-foot: Standard commercially-available orthoses or standard-of-care custom orthoses as well as standard commercially-available electrical stimulation neuro-orthoses.
Prosthetic Limb Users Survey of Mobility Score
Low Profile Foot
56.5 T-score
Standard Deviation 7.665246245
Prosthetic Limb Users Survey of Mobility Score
Energy Storage and Return Foot
53.78 T-score
Standard Deviation 7.3123
Prosthetic Limb Users Survey of Mobility Score
Passive Hydraulic Ankle
53.83 T-score
Standard Deviation 7.898
Prosthetic Limb Users Survey of Mobility Score
Microprocessor Hydraulic Ankle
47.4 T-score
Standard Deviation 5.444

SECONDARY outcome

Timeframe: Weekly time points for Prosthetic interventions (baseline, 1, 2, 3, and 4 weeks), data collected anytime up to 12 weeks on study

Population: All participants did not complete tests with all prostheses.

Change in movement quality will be determined by stride width, participants crossover to each of 4 different conditions at different study visits, data collected up to 12 weeks on study. Stride width is the absolute value of the lateral distance from a line that is fit to the foot placements of 3 strides previous and 3 strides after the current stride, to the foot placement location of the current stride.

Outcome measures

Outcome measures
Measure
Prosthesis User With Transtibial or Transfemoral Amputation
n=6 Participants
Experiments will use standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA). Lower limb prostheses: Standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA).
Orthoses User With Drop-foot
This arm will consists of participants with drop-foot. All of the drop-foot population were persons with Multiple Sclerosis. For participants in this arm, standard commercially-available orthoses or standard-of-care custom orthoses will be used, as well as standard commercially-available electrical stimulation neuro-orthoses. Orthoses for Drop-foot: Standard commercially-available orthoses or standard-of-care custom orthoses as well as standard commercially-available electrical stimulation neuro-orthoses.
Change in Movement Quality as Determined by Stride Width: Prosthesis
Low Profile Foot
0.1328 meters
Standard Deviation 0.03138
Change in Movement Quality as Determined by Stride Width: Prosthesis
Energy Storage and Return Foot
0.1417 meters
Standard Deviation 0.05243
Change in Movement Quality as Determined by Stride Width: Prosthesis
Passive Hydraulic Ankle
0.11526455 meters
Standard Deviation 0.02398894
Change in Movement Quality as Determined by Stride Width: Prosthesis
Microprocessor Hydraulic Ankle
0.1202 meters
Standard Deviation 0.04510

SECONDARY outcome

Timeframe: Baseline, 10 days, and 20 days for Orthotic interventions

Population: Sensor did not work for one participant during the AFO condition.

Change in movement quality will be determined by stride width, participants crossover to different conditions at different study visits, data collected up to 20 days on study. Stride width is the absolute value of the lateral distance from a line that is fit to the foot placements of 3 strides previous and 3 strides after the current stride, to the foot placement location of the current stride.

Outcome measures

Outcome measures
Measure
Prosthesis User With Transtibial or Transfemoral Amputation
n=11 Participants
Experiments will use standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA). Lower limb prostheses: Standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA).
Orthoses User With Drop-foot
This arm will consists of participants with drop-foot. All of the drop-foot population were persons with Multiple Sclerosis. For participants in this arm, standard commercially-available orthoses or standard-of-care custom orthoses will be used, as well as standard commercially-available electrical stimulation neuro-orthoses. Orthoses for Drop-foot: Standard commercially-available orthoses or standard-of-care custom orthoses as well as standard commercially-available electrical stimulation neuro-orthoses.
Change in Movement Quality as Determined by Stride Width: Orthoses
No Intervention
0.045 meters
Standard Deviation 0.010
Change in Movement Quality as Determined by Stride Width: Orthoses
AFO: Sprystep
0.045 meters
Standard Deviation 0.010
Change in Movement Quality as Determined by Stride Width: Orthoses
FES: Bioness
0.047 meters
Standard Deviation 0.014

SECONDARY outcome

Timeframe: Weekly time points for Prosthetic interventions (baseline, 1, 2, 3, and 4 weeks), data collected anytime up to 12 weeks on study

Population: All participants did not complete tests with all prostheses.

Change in gait performance as determined by speed of the participant, participants crossover to each of 4 different conditions at different study visits, data collected up to 12 weeks on study.

Outcome measures

Outcome measures
Measure
Prosthesis User With Transtibial or Transfemoral Amputation
n=6 Participants
Experiments will use standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA). Lower limb prostheses: Standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA).
Orthoses User With Drop-foot
This arm will consists of participants with drop-foot. All of the drop-foot population were persons with Multiple Sclerosis. For participants in this arm, standard commercially-available orthoses or standard-of-care custom orthoses will be used, as well as standard commercially-available electrical stimulation neuro-orthoses. Orthoses for Drop-foot: Standard commercially-available orthoses or standard-of-care custom orthoses as well as standard commercially-available electrical stimulation neuro-orthoses.
Change in Gait Performance as Determined by Average Speed
Low Profile Foot
0.8376 meter per second
Standard Deviation 0.1332
Change in Gait Performance as Determined by Average Speed
Energy Storage and Return Foot
0.8553 meter per second
Standard Deviation 0.1149
Change in Gait Performance as Determined by Average Speed
Passive Hydraulic Ankle
0.8635 meter per second
Standard Deviation 0.1444
Change in Gait Performance as Determined by Average Speed
Microprocessor Hydraulic Ankle
0.9521 meter per second
Standard Deviation 0.08561

SECONDARY outcome

Timeframe: Weekly time points for Prosthetic interventions (baseline, 1, 2, 3, and 4 weeks), data collected anytime up to 12 weeks on study

Population: All participants did not complete tests with all prostheses.

Gait performance as determined by stride frequency at identical speed (included strides with walking speeds between 0.75-1.25 meters per second). Participants crossover to each of 4 different conditions at different study visits, data collected up to 12 weeks on study.

Outcome measures

Outcome measures
Measure
Prosthesis User With Transtibial or Transfemoral Amputation
n=6 Participants
Experiments will use standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA). Lower limb prostheses: Standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA).
Orthoses User With Drop-foot
This arm will consists of participants with drop-foot. All of the drop-foot population were persons with Multiple Sclerosis. For participants in this arm, standard commercially-available orthoses or standard-of-care custom orthoses will be used, as well as standard commercially-available electrical stimulation neuro-orthoses. Orthoses for Drop-foot: Standard commercially-available orthoses or standard-of-care custom orthoses as well as standard commercially-available electrical stimulation neuro-orthoses.
Gait Performance as Determined by Stride Frequency at Identical Speed
Low Profile Foot
67.47 strides per minute
Standard Deviation 3.237
Gait Performance as Determined by Stride Frequency at Identical Speed
Energy Storage and Return Foot
68.22 strides per minute
Standard Deviation 5.835
Gait Performance as Determined by Stride Frequency at Identical Speed
Passive Hydraulic Ankle
67.46 strides per minute
Standard Deviation 4.130
Gait Performance as Determined by Stride Frequency at Identical Speed
Microprocessor Hydraulic Ankle
60.37 strides per minute
Standard Deviation 5.448

SECONDARY outcome

Timeframe: Baseline, 10 days, and 20 days for Orthotic interventions, weekly time points for Prosthetic interventions (baseline, 1, 2, 3, and 4 weeks), data collected anytime up to 12 weeks on study

Population: No data was collected because the force and torque sensor could not be fit into the leg.

Ground reaction force is force applied by the body to the ground. Peak forces and shape of the force vs. time trajectory are commonly used to assess gait quality. Forces closer to "normal" are usually considered better, but this goal does not apply in participants with amputation.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Baseline, 10 days, and 20 days for Orthotic interventions, weekly time points for Prosthetic interventions (baseline, 1, 2, 3, and 4 weeks), data collected anytime up to 12 weeks on study

Population: No data collected because the force and torque sensor could not be fit into the leg.

Socket torque (also termed "socket moment") is the amount of twisting or bending torque applied to the prosthetic socket. Peak socket torque and cumulative socket torque are measures commonly used to assess gait quality in persons with lower limb amputation.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Baseline, 10 days, and 20 days for Orthotic interventions

The Functional Gait Assessment Score will be measured for the sub-population of participants with Multiple Sclerosis (MS). The total score ranges from 0-30 with higher scores indicating increased impairment in gait. Participants crossover to each of three conditions at different study visits.

Outcome measures

Outcome measures
Measure
Prosthesis User With Transtibial or Transfemoral Amputation
n=11 Participants
Experiments will use standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA). Lower limb prostheses: Standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA).
Orthoses User With Drop-foot
This arm will consists of participants with drop-foot. All of the drop-foot population were persons with Multiple Sclerosis. For participants in this arm, standard commercially-available orthoses or standard-of-care custom orthoses will be used, as well as standard commercially-available electrical stimulation neuro-orthoses. Orthoses for Drop-foot: Standard commercially-available orthoses or standard-of-care custom orthoses as well as standard commercially-available electrical stimulation neuro-orthoses.
Change in Functional Gait Assessment Score
No Intervention
16.09 score on a scale
Standard Deviation 5.230
Change in Functional Gait Assessment Score
Ankle Foot Orthosis
17.27 score on a scale
Standard Deviation 6.566
Change in Functional Gait Assessment Score
Functional Electrical Stimulation Device
18.45 score on a scale
Standard Deviation 5.298

SECONDARY outcome

Timeframe: Baseline, 10 days, and 20 days study visits to test conditions for Orthotic interventions

The sub-population of participants with MS will undergo a 6 minute walking test for distance. Each participant will crossover to three conditions over three study visits: No intervention, the carbon fiber ankle foot orthosis (cfAFO), and a functional electrical stimulation (FES) device). Reported here are the difference from No intervention for the cfAFO and FES orthoses, a positive number shows an increase in distance walked due to the intervention.

Outcome measures

Outcome measures
Measure
Prosthesis User With Transtibial or Transfemoral Amputation
n=11 Participants
Experiments will use standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA). Lower limb prostheses: Standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA).
Orthoses User With Drop-foot
This arm will consists of participants with drop-foot. All of the drop-foot population were persons with Multiple Sclerosis. For participants in this arm, standard commercially-available orthoses or standard-of-care custom orthoses will be used, as well as standard commercially-available electrical stimulation neuro-orthoses. Orthoses for Drop-foot: Standard commercially-available orthoses or standard-of-care custom orthoses as well as standard commercially-available electrical stimulation neuro-orthoses.
Change in 6 Minute Walking Test Distance
No Intervention
394.94 meters
Standard Deviation 123.83
Change in 6 Minute Walking Test Distance
AFO: Sprystep
426.73 meters
Standard Deviation 117.87
Change in 6 Minute Walking Test Distance
FES: Bioness
419.09 meters
Standard Deviation 127.16

SECONDARY outcome

Timeframe: Weekly time points for Prosthetic interventions (baseline, 1, 2, 3, and 4 weeks), data collected anytime up to 12 weeks on study

Population: All participants did not complete tests with all prostheses.

Walking speeds from 0.75 to 1.25 meters per second were analyzed, participants crossover to each of 4 different conditions at different study visits, data collected up to 12 weeks on study.

Outcome measures

Outcome measures
Measure
Prosthesis User With Transtibial or Transfemoral Amputation
n=6 Participants
Experiments will use standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA). Lower limb prostheses: Standard commercially available prostheses for participants with lower-limb amputation. Specific prostheses will be determined at the time of the study, but they will include prostheses that are fully passive such as energy storage-and-return (ESR) feet, ESR feet with mobilized ankles such as passive hydraulic ankles (PHA), and ESR feet with microprocessor-controlled ankles (MPA).
Orthoses User With Drop-foot
This arm will consists of participants with drop-foot. All of the drop-foot population were persons with Multiple Sclerosis. For participants in this arm, standard commercially-available orthoses or standard-of-care custom orthoses will be used, as well as standard commercially-available electrical stimulation neuro-orthoses. Orthoses for Drop-foot: Standard commercially-available orthoses or standard-of-care custom orthoses as well as standard commercially-available electrical stimulation neuro-orthoses.
Stride Length at Identical Walking Speed
Energy Storage and Return Foot
1.198 meters
Standard Deviation 0.09409
Stride Length at Identical Walking Speed
Passive Hydraulic Ankle
1.200 meters
Standard Deviation 0.1564
Stride Length at Identical Walking Speed
Microprocessor Hydraulic Ankle
1.302 meters
Standard Deviation 0.1194
Stride Length at Identical Walking Speed
Low Profile Foot
1.196 meters
Standard Deviation 0.1434

Adverse Events

Prosthesis User With Transtibial or Transfemoral Amputation

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Orthoses User With Drop-foot

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Peter Adamczyk

University of Wisconsin - Madison

Phone: (608) 263-3231

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place